Deadline: Tuesday, December 2
The Cardiovascular Genome Phenome Study (CVGPS) is a collaborative effort, spearheaded by the American Heart Association (AHA), to accelerate the future of cardiovascular medicine. CVGPS combines the power of long-term population studies with the precision of molecular analysis to unravel key distinctions between and within subgroups of patients. The discoveries it generates will point the way toward better-targeted, safer, and more effective treatments, based on a deeper understanding of patients’ characteristics, including e.g. risk profiles and therapeutic needs.
To accomplish the promise of the CVGPS, AHA is offering the CVGPS Grand Challenge Award, which is funded at $500,000/year for 4 years for a total of $2 million. AHA will award one Grand Challenge Award this year.
The full application will be available on October 6, 2014 and will have a deadline of December 2, 2014. This is a modification of the timeline previously announced in the Request for Applications.
View more details regarding the CVGPS Grand Challenge Award Application Instructions.
For additional information about the desired characteristics and peer review criteria view the full Request for Applications.